![Barbara Kahlke](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Barbara Kahlke
Director/Miembro de la Junta en tiakis BIOTECH AG .
Perfil
Barbara Kahlke is a Member-Supervisory Board at tiakis BIOTECH AG since 2000.
She was a Secretary & Director at Proteo, Inc. from 2011 to 2012.
Dr. Kahlke holds a doctorate degree from the University of Kiel.
Cargos activos de Barbara Kahlke
Empresas | Cargo | Inicio |
---|---|---|
tiakis BIOTECH AG
![]() tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow. | Director/Miembro de la Junta | 01/05/2000 |
Antiguos cargos conocidos de Barbara Kahlke.
Empresas | Cargo | Fin |
---|---|---|
PROTEO, INC. | Director/Miembro de la Junta | 23/05/2012 |
Formación de Barbara Kahlke.
University of Kiel | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Proteo, Inc.
![]() Proteo, Inc. Pharmaceuticals: MajorHealth Technology Proteo, Inc., a clinical stage drug development company, intends to develop, promote, and market pharmaceuticals and other biotech products. The firm focuses on the development of anti-inflammatory treatments for rare diseases. Its proprietary product Elafin, a human protein that naturally occurs in human skin, lungs, and mammary glands. The company's product is intended for the treatment of post-surgery damage to tissue, pulmonary hypertension, serious injuries caused by accidents, cardiac infarction, and other diseases, as well as for the complications resulting from organ transplantation. It has a license and collaboration agreement with ARTES Biotechnology GmbH to produce Elafin by using the sublicensed yeast HANSENULA POLYMORPHA. The company was founded by Oliver Wiedow and Birge Bargmann on December 18, 1992 and is headquartered in Irvine, CA. | Health Technology |
tiakis BIOTECH AG
![]() tiakis BIOTECH AG BiotechnologyHealth Technology Tiakis BIOTECH AG is a German company that operates as a next generation tissue protective therapeutic technology company. The company is based in Kiel, Germany. Tiakis BIOTECH AG was founded in 2000 by Oliver Wiedow. | Health Technology |
- Bolsa de valores
- Insiders
- Barbara Kahlke